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kinase activity toward Shc
in rat liver
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Insulin induces tyrosine phosphorylation of Shc in cell cultures and in
insulin-sensitive tissues of the intact rat. However, the ability of
insulin receptor (IR) tyrosine kinase to phosphorylate Shc has not been
previously demonstrated. In the present study, we investigated insu-
lin-induced IR tyrosine kinase activity towards Shc. Insulin receptor
was immunoprecipitated from liver extracts, before and after a very
low dose of insulin into the portal vein, and incubated with
immunopurified Shc from liver of untreated rats. The kinase assay was
performed in vitro in the presence of exogenous ATP and the phos-
phorylation level was quantified by immunoblotting with antiphos-
photyrosine antibody. The results demonstrate that Shc interacted with
insulin receptor after infusion of insulin, and, more important, there
was insulin receptor kinase activity towards immunopurified Shc. The
description of this pathway in animal tissue may have an important
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Considerable evidence has been accumu-
lated to indicate that activation of tyrosine
kinase activity is essential for most intracel-
lular signaling pathways (1,2). Many polypep-
tides like insulin, IGF-1, PDGF or EGF, act-
ing through the tyrosine kinase capacity of
their own receptors, lead to the transfer of
phosphate groups of ATP to multiple ty-
rosine residues on the receptor itself, a mech-
anism known as autophosphorylation (3).
Autophosphorylation of tyrosine-kinase
growth factor receptors is required for the
full kinase activity toward their own sub-
strates. Interaction of tyrosine phosphorylat-
ed receptors with various SH2 domain-con-
taining effector molecules is responsible for
downstream signal transduction leading to
biological action (4).
The insulin receptor (IR) tyrosine kinase
is activated by two separate events, where
three residues, Tyr1158, Tyr1162 and Tyr1163,
located in the so-called regulatory loop, ap-
pear to play a central role in this process (5).
First, insulin binding partially increases the
activity of the insulin receptor tyrosine ki-
nase and stimulates its ß-subunit autophos-
phorylation. Second, autophosphorylation of
the insulin receptor fully activates the en-
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zyme toward specific intracellular substrate
proteins (6). The substrate specificity of the
purified insulin receptor tyrosine kinase has
been extensively examined in vitro. The re-
ceptor prefers substrates in which the ty-
rosine residue is preceded by an acidic amino
acid (Y-1 or Y-2 position) and is followed by
a hydrophobic residue (Y+1) (7,8).
These results are consistent with many
studies showing that both insulin receptor
substrate-1 (IRS-1) and Shc (src homology
2/α collagen related), a ubiquitously ex-
pressed intracellular signaling protein, share
a related amino-terminal region called Shc
and the IRS-1 NPXY-binding (SAIN) do-
main, also known as PTB/PI domain (9),
which displays an amino acid sequence simi-
lar to that of the IR specificity, and is able to
recognize and bind to the phosphorylated
Tyr 972 located within the NPX-Tyr(P) mo-
tif of IR (10).
Although the PTB/PI domain of Shc ap-
pears to interact with the insulin receptor
(11), the tyrosine kinase activity of the insu-
lin receptor towards Shc has not been previ-
ously demonstrated. The aim of the present
study was to investigate the tyrosine kinase
activity of the insulin receptor towards Shc,
using partially activated IR and immunopu-
rified Shc from animal tissues.
Six-week-old male Wistar rats (130-150
g) were allowed access to standard rodent
chow and water ad libitum. Food was with-
drawn 4 h before the experiments. The rats
were anesthetized with sodium thiopental
(25 mg/kg body weight, ip) and used 10-15
min later, as soon as anesthesia was assured
by the loss of foot and corneal reflexes. The
abdominal cavity was opened, the portal
vein exposed, and 0.5 ml of saline (0.9%
NaCl) with or without 6 pg of insulin was
injected. Three min after insulin injection,
the liver was removed, minced coarsely, and
homogenized immediately in approximately
10 volumes of solubilization buffer A (50
mM Tris, pH 7.4, 100 mM sodium pyro-
phosphate, 100 mM sodium fluoride, 10 mM
EDTA, 10 mM sodium vanadate, 2 mM
PMSF, 0.1 mg/ml aprotinin, and 1% Triton-
X 100), at 4oC with a Polytron PTA 20S
generator (Brinkmann Instruments model PT
10/35; Westbury, NY) operated at maxi-
mum speed (setting 10) for 30 s. After ex-
traction the samples were centrifuged at
12,000 rpm at 4oC in a Beckman 70.1 Ti
rotor (Beckman, Palo Alto, CA, USA) for 30
min to remove insoluble material, and the
resulting supernatant was used for immuno-
precipitation with anti-insulin receptor or
anti-Shc antibodies. The immune complexes
were precipitated with protein A Sepharose
6MB. After immunoprecipitation Shc pro-
tein was subjected to immunopurification
techniques by washing  three times with a
buffer containing 300 mM NaCl, 0.03% (v/
v) Tween 20, 2 mM PMSF and 0.1 mg/ml
aprotinin. The complexes were then resus-
pended in 30 µl of 0.2 M Na2CO3, pH 11, and
incubated in 20 µl of a buffer containing 1 M
Tris, pH 6.8, 0.02% (v/v) Tween 20, 3 mM
PMSF and 0.1 mg/ml aprotinin. The protein
kinase activity was measured by adding im-
munoprecipitated IR and immunopurified
Shc in 100 µl of buffer containing 50 mM
Tris, pH 7.4, 0.2 mM sodium vanadate, 0.1%
Triton-X 100, 3 mM MnCl2 with or without
15 µM ATP for 30 min at room temperature
(12). The complexes were washed once with
the same kinase buffer and then resuspended
in 20 µl of Laemmli sample buffer with 200
mM DTT (13), and subsequently separated
by 8% SDS-PAGE. Proteins in the gel were
electrophoretically transferred to nitrocellu-
lose in a Bio-Rad miniature transfer appara-
tus (Mini-Protean) as described by Towbin
et al. (14). The incorporation of phosphate
into insulin receptor and Shc was visualized
by autoradiography of anti-phosphotyrosine
immunoblots. The prestained molecular
weight standards used were myosin (194
kDa), ß-galactosidase (116 kDa), bovine se-
rum albumin (85 kDa), and ovalbumin (49
kDa).
When Shc immunopurified from 4-h
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fasted non-insulin stimulated rat liver were
added to immunoprecipitated IR complexes
from liver of rats exposed to 6 pg of insulin
stimulus, a lower basal level of p52Shc phos-
phorylation independent of the ATP in vitro
assay was observed (Figure 1, lane a). After
3 min, a time between maximal IR and Shc
phosphorylation levels in liver after insulin
infusion in vivo, a weak IR tyrosyl phospho-
rylation was also observed, with little in-
crease in the intensity of the lower band (~55
kDa) (Figure 1, lane c). After in vitro cold
ATP addition, the IR and p52Shc bands be-
came stronger than their respective non-ATP-
stimulated bands (Figure 1, lanes b and d),
but IR remained phosphorylated to a lesser
extent than Shc. Two upper weak bands also
appeared. It was previously demonstrated
that these bands are IRS-1 and IRS-2 (15).
Over the past few years, considerable
progress has been made in elucidating the
signaling pathways downstream from ty-
rosine phosphorylation. The data of the pres-
ent study show an already known pattern of
insulin receptor tyrosine phosphorylation
occurring during the early intracellular steps
of insulin signaling in rat liver, which could
be crucial for the insight into the molecular
basis for insulin receptor tyrosine kinase
mitogenic transduction pathways.
The insulin-stimulated phosphorylation
of Shc occurs at physiological post-prandial
insulin levels as shown in Figure 1, and leads
to association with the Grb2-SOS complex
to activate p21ras (16,17), which activates
mitogenesis by activating the mitogen-acti-
vated protein kinase (18). Therefore, a key to
understanding the mechanism of how acti-
Figure 1 - IR tyrosine kinase activity measured
by autophosphorylation with immunopurified
complex. The rats were anesthetized and the
abdominal wall was incised to expose the vis-
cera. Saline or 6 pg of insulin (as indicated in
the figure) was administered as a bolus injec-
tion into the portal vein of the rat and the liver
was excised 3 min (the intermediate between
maximal times of IR and Shc tyrosine phos-
phorylation in liver) after insulin injection to
stimulate partial IR autophosphorylation. IR
was then immunoprecipitated and Shc was
immunopurified as described in Methods, and
then allowed to react in vitro in the presence
of exogenous ATP (lane d). Tyrosine phospho-
rylation was measured by immunoblotting the
ATP-stimulated pellet with an antiphosphoty-
rosine antibody. Control conditions are shown
in lanes a and b. In lane a, the liver extract was
not exposed to insulin or ATP. In lane b, the
liver extract was not exposed to insulin, but
ATP was added to the in vitro autophosphory-
lation reaction. In lane c, insulin (6 pg) was
infused into the portal vein and the liver
extracted after 3 min, but no exogenous ATP
was added during the in vitro phosphorylation
step. In lane d, insulin was infused and ATP
was added to the in vitro phosphorylation reac-
tion. This experiment was performed 5 times
with closely similar results.
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vated insulin receptors increase the amount
of p21ras-GTP lies in the clarification of the
mechanism of linkage between insulin re-
ceptor and Shc.
Shc can interact with tyrosine-phospho-
rylated growth factor receptors in three dif-
ferent ways, either through its SH2 domain
or its amino-terminal domain, or both (16-
18). Increasing evidence indicates that the
amino-terminal domain of Shc is respon-
sible for the binding to phosphotyrosine resi-
dues of the growth factor receptors. Such
evidence was based on cell culture in vitro
assays and also on the sensitive two-hybrid
assay of protein-protein interaction which
demonstrated that Shc interacts directly with
IR (19,20).
Unlike EGF and PDGF receptors, coim-
munoprecipitation studies have not shown
interaction between Shc and the IR in vivo. It
seems that the interaction of Shc with the IR,
in spite of being of sufficient affinity to
localize these molecules adjacent to the IR
kinase to promote phosphorylation, may be
of a low enough affinity to allow these mol-
ecules to rapidly dissociate from the acti-
vated receptor following phosphorylation,
causing a reduced binding affinity of Shc to
the IR, and impairing the analysis of the
association of these two proteins (18).
Our results show that Shc interacts with
the insulin receptor after insulin stimulation
in rat liver. Furthermore, there is a kinase
activity of the insulin receptor towards
immunopurified Shc. We have previously
demonstrated that insulin induces Shc ty-
rosine phosphorylation in rat tissues, and a
kinase activity of the insulin receptor to-
wards Shc was also suggested (15). The
results presented here clearly demonstrate
that the insulin receptor is able to induce
tyrosine phosphorylation of immunopurified
Shc.
It is interesting to note that besides the
insulin receptor and Shc, that was added to
the reaction, two other bands appeared and
became phosphorylated after the addition of
ATP. By immunoblotting with specific anti-
bodies it was previously demonstrated that
these bands correspond to IRS-1 and IRS-2
which probably were bound to the insulin
receptor after insulin stimulation (15).
In summary, we have demonstrated that,
after an infusion of very low doses of insulin
in the intact rat, it is possible to demonstrate
that the insulin receptor has tyrosine kinase
activity toward immunopurified Shc.
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